Lateral Flow Assay Market

Lateral Flow Assay Market by Application (Clinical Testing (Pregnancy, Infectious Disease (Mosquito , Influenza, STI, Hepatitis, TB), Cardiac Marker, Lipid Test) Veterinary, Food Safety) Product (Reader, Kits) Technique, End User - Global Forecast to 2023

Report Code: MD 4158 Nov, 2018, by marketsandmarkets.com

[288 Pages Report] The lateral flow assay market is expected to reach USD 8.7 billion by 2023 from an estimated USD 6.0 billion in 2018, at a CAGR of 7.7%. The study involved four major activities to estimate the current market size for lateral flow assay products. Exhaustive secondary research was done to collect information on market, peer market and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter market breakdown and data triangulation was used to estimate the market size of segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dun & Bradstreet have been referred to, so as to identify and collect information for this study. These secondary sources included annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold standard & silver standard websites, food safety organizations, regulatory bodies, trade directories, and databases.

Primary Research

The lateral flow assay market comprises several stakeholders such as raw material suppliers, processors, end-product manufacturers, distributors, and regulatory organizations in the supply chain. The demand side of this market is characterized by the development of the hospitals & clinics, diagnostic laboratories, home care, food & beverage, pharmaceutical, nutraceutical & biotechnology companies, and environmental testing industry. The supply side is characterized by advancements in technology and diverse application industries. Various primary sources from both, the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.

Lateral Flow Assay Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the lateral flow assay market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size using the market size estimation processes as explained above—the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both, the demand and supply sides.

Objectives of the Study

  • To define, describe, and forecast the global lateral flow assay market on the basis of product, application, technique, end user, and region
  • To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
  • To analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the lateral flow assay market with respect to five main regions (along with major countries), namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa
  • To profile the key players in the global lateral flow assay market and comprehensively analyze their core competencies and their market shares
  • To track and analyze competitive developments such as mergers and acquisitions, product launches, collaborations, agreements, partnerships, and R&D activities of the leading players in the global lateral flow assay market

Scope of the Report

Report Metric

Details

Market size available for years

2016-2023

Base year considered

2017

Forecast period

2018-2023

Forecast units

Value (USD)

Segments covered

Product, Application, Technique, End User, and Region

Geographies covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Companies covered

Abbott Laboratories (US) (Including Alere), F. Hoffmann-La Roche (Switzerland), Danaher Corporation (US), Siemens AG (Germany), Becton, Dickinson and Company (US), bioMιrieux (France), Bio-Rad Laboratories (US), Thermo Fisher Scientific (US), QIAGEN NV (Netherlands), PerkinElmer (US), Hologic, Inc. (US), and Quidel Corporation (US).

The research report categorizes the market into the following segments and subsegments:

Lateral Flow Assay Market, by Product

  • Kits & Reagents
  • Lateral Flow Readers
  • Digital/Mobile Readers
  • Benchtop Readers

Lateral Flow Assay Market, by Application

  • Clinical Testing
    • Infectious Diseases Testing
      • Mosquito-borne Disease Testing
      • Influenza Testing
      • Sexually Transmitted Infection Testing
        • HIV Testing
        • HPV Testing
        • Chlamydia Testing
        • Gonorrhea Testing
        • Syphilis Testing
        • Other STI Testing
      • Hepatitis Testing
      • Tuberculosis Testing
      • Other Infectious diseases
    • Cardiac Markers
      • Troponin I and T Testing
      • CK-MB Testing
      • BNP or NT-proBNP Testing
      • Myoglobin Testing
      • D-Dimer Testing
      • Other Cardiac Marker Testing
    • Pregnancy & Fertility Testing
      • Pregnancy Testing
      • Fertility Testing
    • Cholesterol/Lipid Testing
    • Drugs of Abuse Testing
    • Other Clinical Tests
  • Veterinary Diagnostics 
  • Drug Development & Quality Testing
  • Food Safety & Environmental Safety

Lateral Flow Assay Market, by End User

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Home Care
  • Pharmaceutical and Biotechnology Companies
  • Other End Users

Lateral Flow Assay Market, by Technique

  • Competitive Assays
  • Sandwich Assays
  • Multiplex Detection Assays

Lateral Flow Assay Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Latin America
  • Middle East & Africa

Available Customization

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Further breakdown of the kits & reagents segment of the lateral flow assay market
  • Further segmentation of individual product segments by application and end user

Geographic Analysis

  • Further breakdown of the Latin America,  Rest of Asia Pacific lateral flow assay market into South Korea, Australia, New Zealand, and others
  • Further breakdown of the Rest of Europe lateral flow assay market into Belgium, Russia, the Netherlands, Switzerland, and others

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

The global lateral flow assay market is projected to reach USD 8.7 billion by 2023 from USD 6.0 billion in 2018, at a CAGR of 7.7%. The growth of this market is majorly driven by the high prevalence of infectious diseases worldwide, rapidly growing geriatric population, growing demand for point-of-care testing, and rising use of home-based lateral flow assay devices.

Lateral Flow Assay Market

By product, kits and reagents segment is expected to be the largest contributor in the lateral flow assay market during the forecast period.

The report analyzes the global lateral flow assay market by product, application, technique, end user, and region. On the basis of product, the kits & reagents segment accounted for the largest share in 2017, owing to the increasing application of lateral flow kits & reagents for point-of-care testing, growing burden of chronic diseases, and increasing use of lateral flow kits in home care.

Clinical testing segment is expected to dominate the lateral flow assay market through forecast period

Based on application, the lateral flow assay market is categorized into clinical/point-of-care testing, veterinary diagnostics, food safety & environmental testing, and drug development & quality control testing. In 2017, the clinical/point-of-care testing segment accounted for the largest share of this market. The rise in population levels and prevalence of chronic diseases, growing pressure to reduce healthcare costs, and increasing demand for patient-centric care are the major factors driving the growth of the clinical/POC testing market.

Hospitals & clinics end user segment to contribute the largest share during forecast period

The global lateral flow assay market by end user is segmented into hospitals and clinics, home care, diagnostic laboratories, pharmaceutical & biotechnology companies, and other end users. In 2017, the hospitals and clinics segment accounted for the largest share of the market. The large share of this segment is mainly due to factors, such as technological advancements, increasing adoption of point-of-care testing, innovative technologies and devices, and growing patient inclination toward fast and early diagnosis.

North America is expected to account for the largest share of lateral flow assay market during the forecast period

Geographically, the global lateral flow assay market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2017, North America held the largest share of this market, and this is primarily attributed to the presence of a highly developed healthcare system, rising geriatric population, increasing incidence of chronic diseases, quick adoption of new innovative products, and a large number of lateral flow assay kits manufacturing companies in this region.

Lateral Flow Assay Market

The prominent players in the global lateral flow assay market are Abbott Laboratories (US), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (US), Siemens AG (Germany), Becton, Dickinson and Company (US), bioMιrieux SA (France), Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), QIAGEN N.V. (The Netherlands), PerkinElmer, Inc. (US), Hologic, Inc. (US), Merck Millipore (US), Quidel Corporaton (US), Abcam plc. (US), DCN Diagnostics (US), Surmodics, Inc. (US), BioPorto Diagnostics A/S (Denmark), Chembio Diagnostic Systems, Inc. (US), Polysciences, Inc. (US), Innova Biosciences Ltd. (UK), Microcoat Biotechnologie GmbH (Germany), Senova GmbH (Germany), Scienion AG (Germany), and Orasure Diagnostics (US).

Abbott manufactures and markets diagnostic systems and tests to blood banks, hospitals, commercial laboratories, clinics, physicians' offices, government agencies, alternate care testing sites, and plasma protein therapeutic companies. The company provides immunoassay and clinical chemistry systems including ARCHITECT and ABBOTT PRISM, a full line of hematology systems and reagents known as the Cell-Dyn series; the i-STAT point-of-care diagnostic systems and cartridges for blood analysis; and informatics and automation solutions for use in laboratories. The company focuses on the launch of new products and modification of existing products to maintain its position in the market. The company focuses on acquisitions and agreements to strengthen its position in the market. For instance, the acquisition of Alere (US) established the company as a market leader in the market. The sales increase over the last three years was driven primarily by the 2017 acquisitions of St. Jude Medical and Alere and sales growth in the established pharmaceuticals and diagnostics businesses.

Recent Developments

  • In 2018, F. Hoffmann-La Roche AG (Switzerland) launched Elecsys CSF immunoassays (LFIA )
  • In 2018, Danaher Corporation launched Syva EMIT II Plus 6-AM and BUP assays (Drug of Abuse)
  • In 2017, Abbott Laboratories (US) acquired Alere, Inc. (US) to develop a strong, diverse portfolio of devices, diagnostics, nutritionals, and branded generic pharmaceuticals. Alere was the leading player in lateral flow assay market prior to its acquisition by Abbott.
  • In 2018, Siemens AG (Germany) acquired Fast Track Diagnostics Luxembourg S.ΰ.r.l. FTD’s broad range of CE-marked infectious disease detection tests and syndromic panels expands the Siemens Healthineers product portfolio.

Key question addressed by the report

  • Who are the top 10 players operating lateral flow assay market?
  • What are the driving factors, restraints, opportunities, and challenges in lateral flow assay market?
  • What are the industry trends and current scenario of the lateral flow assay market?
  • What are the growth trends in lateral flow assay market at segmental and overall market levels?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 26)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 30)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Market Breakdown & Data Triangulation
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 41)

4 Premium Insights (Page No. - 45)
    4.1 Market Overview
    4.2 Market: Developed vs Developing Countries/Region
    4.3 Market: Major Countries
    4.4 Geographic Mix: Market
    4.5 Market in Asia Pacific,  By Application and Countries

5 Market Overview (Page No. - 50)
    5.1 Introduction
    5.2 Market Dynamics: Impact Analysis
           5.2.1 Market Drivers
                    5.2.1.1 High Prevalence of Infectious Diseases Across the Globe
                    5.2.1.2 Rapidly Increasing Geriatric Population
                    5.2.1.3 Growing Usage of Home-Based Lateral Flow Assay Devices
                    5.2.1.4 Growing Demand for Point-Of-Care Testing
           5.2.2 Market Restraints
                    5.2.2.1 Reluctance Towards Changing Existing Diagnostic Practices
                    5.2.2.2 Implementation of Excise Duty on Medical Devices in the US
           5.2.3 Market Opportunities
                    5.2.3.1 Evolving Applications of Lateral Flow Assays
                    5.2.3.2 Rising Demand for Lateral Flow Assays in the Food & Beverage Industry
           5.2.4 Challenges
                    5.2.4.1 Limited Reimbursements for Lateral Flow Assay Products

6 Industry Insights (Page No. - 58)
    6.1 Introduction
    6.2 Industry Trends
           6.2.1 Integration of Microfluidic Technology  in Lateral Flow Assays
           6.2.2 Demand for Quantitative Results
           6.2.3 Rising Demand for Multiplexed Lateral Flow Biosensors
    6.3 Value Chain Analysis
    6.4 Supply Chain Analysis
    6.5 Regulatory Analysis
           6.5.1 North America
           6.5.2 Europe
           6.5.3 Asia
                    6.5.3.1 India
                    6.5.3.2 China
                    6.5.3.3 Japan
    6.6 Parent Markets Analysis

7 Market, By Product (Page No. - 70)
    7.1 Introduction
    7.2 Kits & Reagents
           7.2.1 Increasing Demand for Poc Testing is Driving the Demand for Kits and Reagents in the Market
    7.3 Lateral Flow Readers
           7.3.1 Digital/Mobile Readers
                    7.3.1.1 Growing Awareness, Technological Advancements, and High Accuracy are Major Factors Driving the Growth of the Digital/Mobile Readers Market.
           7.3.2 Benchtop Readers
                    7.3.2.1 Lower Diagnosis Cost Per Patient is Driving the Benchtop Readers Market

8 Market, By Application (Page No. - 77)
    8.1 Introduction
    8.2 Clinical Testing
           8.2.1 Infectious Disease Testing
                    8.2.1.1 Mosquito-Borne Disease Testing
                               8.2.1.1.1 Increasing Incidence of Dengue Driving the Growth of the Lateral Flow Assay Market for Mosquito-Borne Testing
                    8.2.1.2 Influenza Testing
                               8.2.1.2.1 Growing Prevalence of Influenza is Expected to Drive the Influenza Testing Market.
                    8.2.1.3 Sexually Transmitted Infection Testing
                               8.2.1.3.1 HIV Testing
                                             8.2.1.3.1.1 Growing Awareness About HIV Poc Testing are the Major Factors Driving Market Growth.
                               8.2.1.3.2 HPV Testing
                                             8.2.1.3.2.1 Rising Adoption of HPV Testing is Expected to Drive the Market During Forecast Period
                               8.2.1.3.3 Chlamydia Testing
                                             8.2.1.3.3.1 Consistantly Growing Incidence of Chlamydia and Rising Awareness Among Patients is Driving This Market
                               8.2.1.3.4 Gonorrhea Testing
                                             8.2.1.3.4.1 The Rising Incidence of Gonorrhea Globally is Expected to Drive the Market During the Forecast Period.
                               8.2.1.3.5 Syphilis Testing
                                             8.2.1.3.5.1 The Growing Adoption of Novel Technologies Supporting the Growth of the Market for Syphilis Testing
                               8.2.1.3.6 Other Sexually Transmitted Infection Testing
                    8.2.1.4 Hepatitis
                               8.2.1.4.1 Nucleic Acid Hybridization-Based Lateral Flow Assays Hold Great Potential in Hepatitis Testing Market
                    8.2.1.5 Tuberculosis
                               8.2.1.5.1 Rising Prevalence of the Disease and A Growing Focus on Early Diagnosis and Treatment of Tuberculosis is Expected to Drive This Market
                    8.2.1.6 Other Infectious Disease Tests
           8.2.2 Cardiac Marker Testing
                    8.2.2.1 Troponin I and T Testing
                               8.2.2.1.1 Introduction of High-Sensitivity Troponin Assays is Expected to Drive This Market During the Forecast Period
                    8.2.2.2 CK-MB Testing
                               8.2.2.2.1 Growing Application of Lateral Flow Tests in Acute Myocardial Injuries is Expected to Drive This Market
                    8.2.2.3 BNP and NT-Probnp Testing
                               8.2.2.3.1 Increasing Demand for Cardiac Biomarker Tests to Detect Heart Stress and Damage to Drive the Growth in This Market
                    8.2.2.4 Myoglobin Testing
                               8.2.2.4.1 Availability of New High-Sensitivity Cardiac Troponin Assays to Restrict the Growth of the Routine Myoglobin Testing Market
                    8.2.2.5 D-Dimer Testing
                               8.2.2.5.1 The Rising Incidence of Cardiovascular Diseases Globally is Expected to Drive the Market for D-Dimer Tests
                    8.2.2.6 Other Cardiac Marker Tests
           8.2.3 Pregnancy & Fertility Testing
                    8.2.3.1 Pregnancy Testing
                               8.2.3.1.1 Pregnancy Testing is Among Well-Established Application Areas for Lateral Flow Assays, Registering Slower Growth During the Forecast Period
                    8.2.3.2 Fertility Testing
                               8.2.3.2.1 Rising Infertility Rates Across the Globe Driving the Demand for Poc Fertility Testing Kits.
           8.2.4 Cholesterol Testing/Lipid Profile
                    8.2.4.1 The Growing Prevalence of Obesity and Cvd is the Key Factor Driving Market Growth
           8.2.5 Drugs of Abuse Testing
                    8.2.5.1 Technological Advancements, Rising Public Awareness, and Growing Focus on Workplace Drug Testing is Driving the Drugs of Abuse Testing Market
           8.2.6 Other Clinical Tests Market
    8.3 Veterinary Diagnostics
           8.3.1 Infectious Disease Outbreaks (Particularly in Large Livestock Animals) is Driving the Demand for  Lateral Flow Tests
    8.4 Food Safety & Environment Testing
           8.4.1 High Sensitivity and Ease of Use Driving the Demand for Lateral Flow Assays for Food Safety Testing
    8.5 Drug Development & Quality Testing
           8.5.1 Increasing Focus on Product Safety and Quality Assurance is Driving the Growth of This Market

9 Market, By Technique (Page No. - 118)
    9.1 Introduction
    9.2 Sandwich Assays
           9.2.1 Wide Applications of Sandwich Assays in Clinical Testing Contributing to the Largest Share of This Segment
    9.3 Competitive Assays
           9.3.1 Hormone Testing, Drug Testing, and Drugs of Abuse Testing are Primary Application Areas of Competitive Assays
    9.4 Multiplex Detection Assays
           9.4.1 Increasing Adoption of Multi-Analyte Assays Among Clinicians to Drive the Growth of This Market

10 Market, By End User (Page No. - 123)
     10.1 Introduction
     10.2 Hospitals & Clinics
             10.2.1 Increasing Use of Poc Tests and Faster Diagnosis Driving Adoption of Lateral Flow Assays Among Hospitals & Clinics
     10.3 Diagnostic Laboratories
             10.3.1 Laboratory Testing is Largely Preferred Over Professional Settings for Urine and Blood Testing
     10.4 Home Care
             10.4.1 Growing Acceptance of Home and Remote Monitoring Driving the Growth of the Market for Home Care
     10.5 Pharmaceutical & Biotechnology Companies
             10.5.1 Increasing Focus on Product Safety Expected to Drive the Growth of the Assays Market Among Pharmaceutical and Biotech Companies
     10.6 Others End Users

11 Market, By Region (Page No. - 131)
     11.1 Introduction
     11.2 North America
             11.2.1 US
                       11.2.1.1 The US Accounts for the Largest Share of the Global Market
             11.2.2 Canada
                       11.2.2.1 The Availability of Research Funding and Implementation of Favorable Government Initiatives is Driving the Market in Canada
     11.3 Europe
             11.3.1 Germany
                       11.3.1.1 Along With Home Care, Growing Number of the Poc Diagnostics Centers Driving the Demand for Lateral Flow Assays in Germany
             11.3.2 France
                       11.3.2.1 Prevalence of Age-Related Chronic Diseases and Infectious Diseases is Expected to Drive the Market Growth in France
             11.3.3 UK
                       11.3.3.1 Increasing Incidence of Chronic Diseases and Rising Prevalence of Obesity Propelling the Market Growth in the UK
             11.3.4 Italy
                       11.3.4.1 Growing Initiatives Towards Decentralization of Medical Services in Italy is Contributing to the Market Growth in the Country
             11.3.5 Spain
                       11.3.5.1 Increasing Focus of International Organizations and Domestic Players Toward the Development of Poc Products in the Country
             11.3.6 Rest of Europe
     11.4 Asia Pacific
             11.4.1 China
                       11.4.1.1 Along With Clinical Diagnostics, the Growing Adoption of Lateral Flow Assays in Veterinary Diagnostics and Drug Development Expected to Drive the Market Growth in China
             11.4.2 Japan
                       11.4.2.1 Increasing Prevalence of Age-Related Illnesses, Attributed to the Growth in Country’s Geriatric Population Driving the Growth of the Market in Japan
             11.4.3 India
                       11.4.3.1 Increasing Prevalence of Chronic Disorders, Growing Healthcare Concerns, and Rising Income Levels is Expected to Propel the Growth of This Market
             11.4.4 Rest of Asia Pacific
     11.5 Latin America
             11.5.1 Increasing Incidence of Chronic Diseases Driving the Demand for Lateral Flow Assays in Latin America
     11.6 Middle East & Africa
             11.6.1 Significant Support From the Governments and Global Firms Towards Expansion of Healthcare Services is Driving Adoption of Lateral Flow Assays in the African Region

12 Competitive Landscape (Page No. - 223)
     12.1 Introduction
     12.2 Product Portfolio Analysis
     12.3 Geographical Assessment of Major Players in the Market
     12.4 Market Share Analysis (2017)
     12.5 Competitive Situations and Trends
             12.5.1 Product Launches
             12.5.2 Acquisitions
             12.5.3 Agreements, Collaborations, and Partnerships
             12.5.4 Expansions
     12.6 Competitive Assessment of R&D Expenditure

13 Company Profiles (Page No. - 231)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
     13.1 ABBOTT Laboratories
     13.2 F. Hoffmann-La Roche AG
     13.3 Danaher Corporation
     13.4 Siemens AG
     13.5 Becton, Dickinson and Company
     13.6 bioMιrieux SA
     13.7 Bio-Rad Laboratories, Inc.
     13.8 Thermo Fisher Scientific Inc.
     13.9 QIAGEN N.V.
     13.10 PerkinElmer Inc.
     13.11 Hologic Inc.
     13.12 Quidel Corporation
     13.13 Merck KGaA

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 279)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.4 Available Customizations
     14.5 Related Reports
     14.6 Author Details


List of Tables (249 Tables)

Table 1 Standard Currency Conversion Rates (Unit of USD)
Table 2 Prevalence of HIV Worldwide (2016-2017)
Table 3 Regulatory Standard/Approval Required for Lateral Flow Immunoassay Products, By Country/Region
Table 4 Market, By Product, 2016–2023 (USD Million)
Table 5 Lateral Flow Assay Kits & Reagents Market, By Country, 2016–2023 (USD Million)
Table 6 Lateral Flow Readers in the Market
Table 7 Lateral Flow Readers Market, By Type, 2016–2023 (USD Million)
Table 8 Lateral Flow Readers Market, By Country, 2016–2023 (USD Million)
Table 9 Digital/Mobile Readers Market, By Country, 2016–2023 (USD Million)
Table 10 Benchtop Readers Market, By Country, 2016–2023 (USD Million)
Table 11 Market, By Application, 2016–2023 (USD Million)
Table 12 Market for Clinical Testing, By Type, 2016–2023 (USD Million)
Table 13 Market for Clinical Testing, By Country, 2016–2023 (USD Million)
Table 14 Infectious Disease Testing Market, By Type, 2016–2023 (USD Million)
Table 15 Infectious Disease Testing Market, By Country, 2016–2023 (USD Million)
Table 16 Major Products: Dengue Testing
Table 17 Mosquito-Borne Disease Testing Market, By Country, 2016–2023 (USD Million)
Table 18 Influenza Testing Market, By Country, 2016–2023 (USD Million)
Table 19 Sexually Transmitted Infection Testing Market, By Type, 2016–2023 (USD Million)
Table 20 Sexually Transmitted Infection Testing Market, By Country, 2016–2023 (USD Million)
Table 21 HIV Testing Market, By Country, 2016–2023 (USD Million)
Table 22 HPV Testing Market, By Country, 2016–2023 (USD Million)
Table 23 Incidence of Chlamydia, By Country, 2010–2016 (‘000)
Table 24 Chlamydia Testing Market, By Country, 2016–2023 (USD Million)
Table 25 Gonorrhea Testing Market, By Country, 2016–2023 (USD Million)
Table 26 Incidence of Syphilis, By Country, 2010–2016
Table 27 Syphilis Testing Market, By Country, 2016–2023 (USD Million)
Table 28 Other Sexually Transmitted Infection Testing Market, By Country,  2016–2023 (USD Million)
Table 29 Hepatitis Testing Market, By Country, 2016–2023 (USD Million)
Table 30 Tuberculosis Testing Market, By Country, 2016–2023 (USD Million)
Table 31 Other Infectious Disease Tests Market, By Country, 2016–2023 (USD Million)
Table 32 Cardiac Marker Testing Market, By Type, 2016–2023 (USD Million)
Table 33 Cardiac Marker Testing Market, By Country, 2016–2023 (USD Million)
Table 34 Troponin I and T Testing Market, By Country, 2016–2023 (USD Million)
Table 35 CK-MB Testing Market, By Country, 2016–2023 (USD Million)
Table 36 BNP & NT-Probnp Testing Market, By Country, 2016–2023 (USD Million)
Table 37 Myoglobin Testing Market, By Country, 2016–2023 (USD Million)
Table 38 D-Dimer Testing Market, By Country, 2016–2023 (USD Million)
Table 39 Other Cardiac Marker Tests Market, By Country, 2016–2023 (USD Million)
Table 40 Pregnancy & Fertility Testing Market, By Type, 2016–2023 (USD Million)
Table 41 Pregnancy & Fertility Testing Market, By Country, 2016–2023 (USD Million)
Table 42 Pregnancy Testing Market, By Country, 2016–2023 (USD Million)
Table 43 Fertility Testing Market, By Country, 2016–2023 (USD Million)
Table 44 Cholesterol Testing/Lipid Profile Market, By Country, 2016–2023 (USD Million)
Table 45 Drugs of Abuse Testing Market, By Country, 2016–2023 (USD Million)
Table 46 Other Clinical Tests Market, By Country, 2016–2023 (USD Million)
Table 47 Market for Veterinary Diagnostics, By Country,  2016–2023 (USD Million)
Table 48 Market for Food Safety & Environmental Testing,  By Country, 2016–2023 (USD Million)
Table 49 Market for Drug Development & Quality Testing,  By Country, 2016–2023 (USD Million)
Table 50 Market, By Technique, 2016–2023 (USD Million)
Table 51 Lateral Flow Sandwich Assays Market, By Country, 2016–2023 (USD Million)
Table 52 Lateral Flow Competitive Assays Market, By Country, 2016–2023 (USD Million)
Table 53 Lateral Flow Multiplex Detection Assays Market, By Country, 2016–2023 (USD Million)
Table 54 Market, By End User, 2016–2023 (USD Million)
Table 55 Market for Hospitals & Clinics, By Country, 2016–2023 (USD Million)
Table 56 Market for Diagnostic Laboratories, By Country,  2016–2023 (USD Million)
Table 57 Market for Home Care, By Country, 2016–2023 (USD Million)
Table 58 Market for Pharmaceutical & Biotechnology Companies, By Country, 2016–2023 (USD Million)
Table 59 Market for Other End Users, By Country, 2016–2023 (USD Million)
Table 60 Lateral Flow Assay Market, By Region, 2016–2023 (USD Million)
Table 61 North America: Macroeconomic Indicators
Table 62 North America: Market, By Country, 2016–2023 (USD Million)
Table 63 North America: Market, By Product, 2016–2023 (USD Million)
Table 64 North America: Lateral Flow Readers Market, By Type, 2016–2023 (USD Million)
Table 65 North America: Market, By Application, 2016–2023 (USD Million)
Table 66 North America: Clinical Testing Market, By Type, 2016–2023 (USD Million)
Table 67 North America: Infectious Disease Testing Market, By Type, 2016–2023 (USD Million)
Table 68 North America: Sexually Transmitted Infection Testing Market, By Type,  2016–2023 (USD Million)
Table 69 North America: Cardiac Marker Testing Market, By Type, 2016–2023 (USD Million)
Table 70 North America: Pregnancy & Fertility Testing Market, By Type, 2016–2023 (USD Million)
Table 71 North America: Market, By Technique, 2016–2023 (USD Million)
Table 72 North America: Market, By End User, 2016–2023 (USD Million)
Table 73 US: Macroeconomic Indicators
Table 74 US: Market, By Product, 2016–2023 (USD Million)
Table 75 US: Lateral Flow Readers Market, By Type, 2016–2023 (USD Million)
Table 76 US: Market, By Application, 2016–2023 (USD Million)
Table 77 US: Clinical Testing Market, By Type, 2016–2023 (USD Million)
Table 78 US: Infectious Disease Testing Market, By Type, 2016–2023 (USD Million)
Table 79 US: Sexually Transmitted Infection Testing Market, By Type, 2016–2023 (USD Million)
Table 80 US: Cardiac Marker Testing Market, By Type, 2016–2023 (USD Million)
Table 81 US: Pregnancy & Fertility Testing Market, By Type, 2016–2023 (USD Million)
Table 82 US: Lateral Flow Assay Market, By Technique, 2016–2023 (USD Million)
Table 83 US: Market, By End User, 2016–2023 (USD Million)
Table 84 Canada: Macroeconomic Indicators
Table 85 Canada: Market, By Product, 2016–2023 (USD Million)
Table 86 Canada: Lateral Flow Readers Market, By Type, 2016–2023 (USD Million)
Table 87 Canada: Market, By Application, 2016–2023 (USD Million)
Table 88 Canada: Clinical Testing Market, By Type, 2016–2023 (USD Million)
Table 89 Canada: Infectious Disease Testing Market, By Type, 2016–2023 (USD Million)
Table 90 Canada: Sexually Transmitted Infection Testing Market, By Type, 2016–2023 (USD Million)
Table 91 Canada: Cardiac Marker Testing Market, By Type, 2016–2023 (USD Million)
Table 92 Canada: Pregnancy & Fertility Testing Market, By Type, 2016–2023 (USD Million)
Table 93 Canada: Market, By Technique, 2016–2023 (USD Million)
Table 94 Canada: Market, By End User, 2016–2023 (USD Million)
Table 95 Europe: Market, By Country, 2016–2023 (USD Million)
Table 96 Europe: Market, By Product, 2016–2023 (USD Million)
Table 97 Europe: Lateral Flow Readers Market, By Type, 2016–2023 (USD Million)
Table 98 Europe: Market, By Application, 2016–2023 (USD Million)
Table 99 Europe: Clinical Testing Market, By Type, 2016–2023 (USD Million)
Table 100 Europe: Infectious Disease Testing Market, By Type, 2016–2023 (USD Million)
Table 101 Europe: Sexually Transmitted Infection Testing Market, By Type, 2016–2023 (USD Million)
Table 102 Europe: Cardiac Marker Testing Market, By Type, 2016–2023 (USD Million)
Table 103 Europe: Pregnancy & Fertility Testing Market, By Type, 2016–2023 (USD Million)
Table 104 Europe: Lateral Flow Assay Market, By Technique, 2016–2023 (USD Million)
Table 105 Europe: Market, By End User, 2016–2023 (USD Million)
Table 106 Germany: Macroeconomic Indicators
Table 107 Germany: Market, By Product, 2016–2023 (USD Million)
Table 108 Germany: Lateral Flow Readers Market, By Type, 2016–2023 (USD Million)
Table 109 Germany: Market, By Application, 2016–2023 (USD Million)
Table 110 Germany: Clinical Testing Market, By Type, 2016–2023 (USD Million)
Table 111 Germany: Infectious Disease Testing Market, By Type, 2016–2023 (USD Million)
Table 112 Germany: Sexually Transmitted Infection Testing Market, By Type,  2016–2023 (USD Million)
Table 113 Germany: Cardiac Marker Testing Market, By Type, 2016–2023 (USD Million)
Table 114 Germany: Pregnancy & Fertility Testing Market, By Type, 2016–2023 (USD Million)
Table 115 Germany: Market, By Technique, 2016–2023 (USD Million)
Table 116 Germany: Market, By End User, 2016–2023 (USD Million)
Table 117 France: Macroeconomic Indicators
Table 118 France: Market, By Product, 2016–2023 (USD Million)
Table 119 France: Lateral Flow Readers Market, By Type, 2016–2023 (USD Million)
Table 120 France: Lateral Flow Assay Market, By Application, 2016–2023 (USD Million)
Table 121 France: Clinical Testing Market, By Type, 2016–2023 (USD Million)
Table 122 France: Infectious Disease Testing Market, By Type, 2016–2023 (USD Million)
Table 123 France: Sexually Transmitted Infection Testing Market, By Type, 2016–2023 (USD Million)
Table 124 France: Cardiac Marker Testing Market, By Type, 2016–2023 (USD Million)
Table 125 France: Pregnancy & Fertility Testing Market, By Type, 2016–2023 (USD Million)
Table 126 France: Market, By Technique, 2016–2023 (USD Million)
Table 127 France: Market, By End User, 2016–2023 (USD Million)
Table 128 UK: Macroeconomic Indicators
Table 129 UK: Market, By Product, 2016–2023 (USD Million)
Table 130 UK: Lateral Flow Readers Market, By Type, 2016–2023 (USD Million)
Table 131 UK: Market, By Application, 2016–2023 (USD Million)
Table 132 UK: Clinical Testing Market, By Type, 2016–2023 (USD Million)
Table 133 UK: Infectious Disease Testing Market, By Type, 2016–2023 (USD Million)
Table 134 UK: Sexually Transmitted Infection Testing Market, By Type, 2016–2023 (USD Million)
Table 135 UK: Cardiac Marker Testing Market, By Type, 2016–2023 (USD Million)
Table 136 UK: Pregnancy & Fertility Testing Market, By Type, 2016–2023 (USD Million)
Table 137 UK: Market, By Technique, 2016–2023 (USD Million)
Table 138 UK: Market, By End User, 2016–2023 (USD Million)
Table 139 Italy: Macroeconomic Indicators
Table 140 Italy: Lateral Flow Assay Market, By Product, 2016–2023 (USD Million)
Table 141 Italy: Lateral Flow Readers Market, By Type, 2016–2023 (USD Million)
Table 142 Italy: Market, By Application, 2016–2023 (USD Million)
Table 143 Italy: Clinical Testing Market, By Type, 2016–2023 (USD Million)
Table 144 Italy: Infectious Disease Testing Market, By Type, 2016–2023 (USD Million)
Table 145 Italy: Sexually Transmitted Infection Testing Market, By Type, 2016–2023 (USD Million)
Table 146 Italy: Cardiac Marker Testing Market, By Type, 2016–2023 (USD Million)
Table 147 Italy: Pregnancy & Fertility Testing Market, By Type, 2016–2023 (USD Million)
Table 148 Italy: Market, By Technique, 2016–2023 (USD Million)
Table 149 Italy: Market, By End User, 2016–2023 (USD Million)
Table 150 Spain: Macroeconomic Indicators
Table 151 Spain: Market, By Product, 2016–2023 (USD Million)
Table 152 Spain: Lateral Flow Readers Market, By Type, 2016–2023 (USD Million)
Table 153 Spain: Market, By Application, 2016–2023 (USD Million)
Table 154 Spain: Clinical Testing Market, By Type, 2016–2023 (USD Million)
Table 155 Spain: Infectious Disease Testing Market, By Type, 2016–2023 (USD Million)
Table 156 Spain: Sexually Transmitted Infection Testing Market, By Type, 2016–2023 (USD Million)
Table 157 Spain: Cardiac Marker Testing Market, By Type, 2016–2023 (USD Million)
Table 158 Spain: Pregnancy & Fertility Testing Market, By Type, 2016–2023 (USD Million)
Table 159 Spain: Lateral Flow Assay Market, By Technique, 2016–2023 (USD Million)
Table 160 Spain: Market, By End User, 2016–2023 (USD Million)
Table 161 RoE: Market, By Product, 2016–2023 (USD Million)
Table 162 RoE: Lateral Flow Readers Market, By Type, 2016–2023 (USD Million)
Table 163 RoE: Market, By Application, 2016–2023 (USD Million)
Table 164 RoE: Clinical Testing Market, By Type, 2016–2023 (USD Million)
Table 165 RoE: Infectious Disease Testing Market, By Type, 2016–2023 (USD Million)
Table 166 RoE: Sexually Transmitted Infection Testing Market, By Type, 2016–2023 (USD Million)
Table 167 RoE: Cardiac Marker Testing Market, By Type, 2016–2023 (USD Million)
Table 168 RoE: Pregnancy & Fertility Testing Market, By Type, 2016–2023 (USD Million)
Table 169 RoE: Market, By Technique, 2016–2023 (USD Million)
Table 170 RoE: Market, By End User, 2016–2023 (USD Million)
Table 171 APAC: Market, By Country, 2016–2023 (USD Million)
Table 172 APAC: Market, By Product, 2016–2023 (USD Million)
Table 173 APAC: Lateral Flow Readers Market, By Type, 2016–2023 (USD Million)
Table 174 APAC: Lateral Flow Assay Market, By Application, 2016–2023 (USD Million)
Table 175 APAC: Clinical Testing Market, By Type, 2016–2023 (USD Million)
Table 176 APAC: Infectious Disease Testing Market, By Type, 2016–2023 (USD Million)
Table 177 APAC: Sexually Transmitted Infection Testing Market, By Type, 2016–2023 (USD Million)
Table 178 APAC: Cardiac Marker Testing Market, By Type, 2016–2023 (USD Million)
Table 179 APAC: Pregnancy & Fertility Testing Market, By Type, 2016–2023 (USD Million)
Table 180 APAC: Market, By Technique, 2016–2023 (USD Million)
Table 181 APAC: Market, By End User, 2016–2023 (USD Million)
Table 182 China: Macroeconomic Indicators
Table 183 China: Market, By Product, 2016–2023 (USD Million)
Table 184 China: Lateral Flow Readers Market, By Type, 2016–2023 (USD Million)
Table 185 China: Market, By Application, 2016–2023 (USD Million)
Table 186 China: Clinical Testing Market, By Type, 2016–2023 (USD Million)
Table 187 China: Infectious Disease Testing Market, By Type, 2016–2023 (USD Million)
Table 188 China: Sexually Transmitted Infection Testing Market, By Type,  2016–2023 (USD Million)
Table 189 China: Cardiac Marker Testing Market, By Type, 2016–2023 (USD Million)
Table 190 China: Pregnancy & Fertility Testing Market, By Type, 2016–2023 (USD Million)
Table 191 China: Market, By Technique, 2016–2023 (USD Million)
Table 192 China:Market, By End User, 2016–2023 (USD Million)
Table 193 Japan: Macroeconomic Indicators
Table 194 Japan: Market, By Product, 2016–2023 (USD Million)
Table 195 Japan: Lateral Flow Readers Market, By Type, 2016–2023 (USD Million)
Table 196 Japan: Market, By Application, 2016–2023 (USD Million)
Table 197 Japan: Clinical Testing Market, By Type, 2016–2023 (USD Million)
Table 198 Japan: Infectious Disease Testing Market, By Type, 2016–2023 (USD Million)
Table 199 Japan: Sexually Transmitted Infection Testing Market, By Type, 2016–2023 (USD Million)
Table 200 Japan: Cardiac Marker Testing Market, By Type, 2016–2023 (USD Million)
Table 201 Japan: Pregnancy & Fertility Testing Market, By Type, 2016–2023 (USD Million)
Table 202 Japan: Market, By Technique, 2016–2023 (USD Million)
Table 203 Japan: Market, By End User, 2016–2023 (USD Million)
Table 204 India: Macroeconomic Indicators
Table 205 India: Market, By Product, 2016–2023 (USD Million)
Table 206 India: Lateral Flow Readers Market, By Type, 2016–2023 (USD Million)
Table 207 India: Market, By Application, 2016–2023 (USD Million)
Table 208 India: Clinical Testing Market, By Type, 2016–2023 (USD Million)
Table 209 India: Infectious Disease Testing Market, By Type, 2016–2023 (USD Million)
Table 210 India: Sexually Transmitted Infection Testing Market, By Type, 2016–2023 (USD Million)
Table 211 India: Cardiac Marker Testing Market, By Type, 2016–2023 (USD Million)
Table 212 India: Pregnancy & Fertility Testing Market, By Type, 2016–2023 (USD Million)
Table 213 India: Market, By Technique, 2016–2023 (USD Million)
Table 214 India: Market, By End User, 2016–2023 (USD Million)
Table 215 RoAPAC: Market, By Product, 2016–2023 (USD Million)
Table 216 RoAPAC: Lateral Flow Readers Market, By Type, 2016–2023 (USD Million)
Table 217 RoAPAC: Market, By Application, 2016–2023 (USD Million)
Table 218 RoAPAC: Clinical Testing Market, By Type, 2016–2023 (USD Million)
Table 219 RoAPAC: Infectious Disease Testing Market, By Type, 2016–2023 (USD Million)
Table 220 RoAPAC: Sexually Transmitted Infection Testing Market, By Type, 2016–2023 (USD Million)
Table 221 RoAPAC: Cardiac Marker Testing Market, By Type, 2016–2023 (USD Million)
Table 222 RoAPAC: Pregnancy & Fertility Testing Market, By Type, 2016–2023 (USD Million)
Table 223 RoAPAC: Market, By Technique, 2016–2023 (USD Million)
Table 224 RoAPAC: Market, By End User, 2016–2023 (USD Million)
Table 225 Brazil: Macroeconomic Indicators
Table 226 Latin America: Market, By Product, 2016–2023 (USD Million)
Table 227 Latin America: Lateral Flow Readers Market, By Type, 2016–2023 (USD Million)
Table 228 Latin America: Market, By Application, 2016–2023 (USD Million)
Table 229 Latin America: Clinical Testing Market, By Type, 2016–2023 (USD Million)
Table 230 Latin America: Infectious Disease Testing Market, By Type, 2016–2023 (USD Million)
Table 231 Latin America: Sexually Transmitted Infection Testing Market, By Type, 2016–2023 (USD Million)
Table 232 Latin America: Cardiac Marker Testing Market, By Type, 2016–2023 (USD Million)
Table 233 Latin America: Pregnancy & Fertility Testing Market, By Type, 2016–2023 (USD Million)
Table 234 Latin America: Market, By Technique, 2016–2023 (USD Million)
Table 235 Latin America: Market, By End User, 2016–2023 (USD Million)
Table 236 Middle East & Africa: Market, By Product, 2016–2023 (USD Million)
Table 237 Middle East & Africa: Lateral Flow Readers Market, By Type, 2016–2023 (USD Million)
Table 238 Middle East & Africa: Market, By Application, 2016–2023 (USD Million)
Table 239 Middle East & Africa: Clinical Testing Market, By Type, 2016–2023 (USD Million)
Table 240 Middle East & Africa: Infectious Disease Testing Market, By Type, 2016–2023 (USD Million)
Table 241 Middle East & Africa: Sexually Transmitted Infection Testing Market, By Type, 2016–2023 (USD Million)
Table 242 Middle East & Africa: Cardiac Marker Testing Market, By Type, 2016–2023 (USD Million)
Table 243 Middle East & Africa: Pregnancy & Fertility Testing Market, By Type,  2016–2023 (USD Million)
Table 244 Middle East & Africa: Market, By Technique, 2016–2023 (USD Million)
Table 245 Middle East & Africa: Market, By End User, 2016–2023 (USD Million)
Table 246 Product Launches (2018)
Table 247 Acquisitions (2017-2018)
Table 248 Collaborations, Agreement, and Partnerships (2017-2018)
Table 249 Expansions (2016-2017)
 
 
List of Figures (56 Figures)
 
Figure 1 Market
Figure 2 Research Design
Figure 3 Primary Sources
Figure 4 Breakdown of Primary Interviews (Supply Side): By Company Type, Designations, and Region
Figure 5 Breakdown of Primary Interviews (Demand Side): By End User, Designations, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Market, By Product, 2018 vs 2023 (USD Million)
Figure 8 Market, By Technique,  2018 vs 2023 (USD Million)
Figure 9 Market, By Application,  2018 vs 2023 (USD Million)
Figure 10 Market, By End User, 2018 vs 2023 (USD Million)
Figure 11 Geographical Snapshot of the Market
Figure 12 Rapid Growth in the Geriatric Population–Key Factor Driving Market Growth for Lateral Flow Assays
Figure 13 Developing Markets to Register Higher Growth During the Forecast Period
Figure 14 China to Grow at the Fastest Rate During Forecast Period
Figure 15 North America Will Continue to Dominate the Market Through 2023
Figure 16 Clinical Testing Segment and China Commanded the Largest Share of the Asia Pacific Lateral Flow Assays Market in 2017
Figure 17 Prevalence of Infectious Diseases Worldwide
Figure 18 Global Geriatric Population, By Region, 2010 vs 2015 vs 2030
Figure 19 Elderly Population, By Country, 2010 vs 2017 (Million)
Figure 20 Market: Value Chain Analysis (2017)
Figure 21 Market: Supply Chain Analysis (2017)
Figure 22 Microfluidics Market to Register the Highest CAGR From  2018 to 2023
Figure 23 In Vitro Diagnostics: Market Snapshot
Figure 24 Point-Of-Care Diagnostics: Market Snapshot
Figure 25 Microfluidics Market: Market Snapshot
Figure 26 Capillary Electrophoresis Systems: Market Snapshot
Figure 27 Kits & Reagents Segment Will Continue to Dominate the Global Lateral Flow Assays Market in 2023
Figure 28 Clinical Testing Segment to Dominate the Lateral Flow Assays Market, By Application, During the Forecast Period
Figure 29 Patients Being Treated for HIV Globally, 2000–2015
Figure 30 Sandwich Assays to Dominate the Lateral Flow Assays Market During the Forecast Period
Figure 31 Hospitals & Clinics to Dominate the Lateral Flow Assays Market During the Forecast Period
Figure 32 North America to Dominate the Market During Forecast Period
Figure 33 China to Grow at the Fastest Rate During the Forecast Period
Figure 34 North America: Lateral Flow Assays Market Snapshot
Figure 35 Europe: Lateral Flow Assays Market Snapshot
Figure 36 Asia Pacific: Lateral Flow Assays Market Snapshot
Figure 37 Key Developments in the Lateral Flow Assays Market Between 2015 and 2018
Figure 38 Lateral Flow Assay Product Portfolio Matrix
Figure 39 Geographical Revenue Mix: Lateral Flow Assays Market (2017)
Figure 40 Lateral Flow Assays Market Share Analysis, By Key Player (2017)
Figure 41 R&D Expenditure: Major Players in the Lateral Flow Assays Market 2015 & 2017
Figure 42 ABBOTT Laboratories: Company Snapshot (2017)
Figure 43 F. Hoffmann-La Roche AG : Company Snapshot (2017)
Figure 44 Danaher Corporation: Company Snapshot (2017)
Figure 45 Siemens AG : Company Snapshot (2017)
Figure 46 Becton, Dickinson and Company: Company Snapshot (2017)
Figure 47 bioMιrieux SA: Company Snapshot (2017)
Figure 48 Bio-Rad Laboratories, Inc.: Company Snapshot (2017)
Figure 49 Thermo Fisher Scientific Inc.: Company Snapshot (2017)
Figure 50 QIAGEN N.V.: Company Snapshot (2017)
Figure 51 PerkinElmer Inc.: Company Snapshot (2017)
Figure 52 Hologic, Inc.: Company Snapshot (2017)
Figure 53 Quidel Corporation: Company Snapshot (2017)
Figure 54 Merck KGaA: Company Snapshot (2017)
Figure 55 Knowledge Store Snapshot
Figure 56 Marketsandmarkets Knowledge Store: Healthcare Industry Snapshot


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 4158
Published ON
Nov, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Lateral Flow Assay Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved